Amedeo Smart

Free Medical Literature Service

 

Amedeo

Parasitic Diseases
  Free Subscription

Articles published in
Clin Infect Dis
    January 2024
  1. VAN GRIENSVEN J, van Henten S, Kibret A, Kassa M, et al
    Chronic high level parasitemia in HIV-infected individuals with or without visceral leishmaniasis in an endemic area in North-West Ethiopia: potential superspreaders?
    Clin Infect Dis. 2024 Jan 9:ciae002. doi: 10.1093.
    >> Share

    November 2023
  2. VAN SCHALKWYK DA, Pratt S, Nolder D, Stewart LB, et al
    Treatment failure in a UK malaria patient harbouring genetically variant Plasmodium falciparum from Uganda with reduced in vitro susceptibility to artemisinin and lumefantrine.
    Clin Infect Dis. 2023 Nov 29:ciad724. doi: 10.1093.
    >> Share

    August 2023
  3. COLT S, Miller CD, Edielu A, Webb EL, et al
    Relationships between Schistosoma mansoni infection intensity and nutritional status and anemia among preschool-aged children in Uganda.
    Clin Infect Dis. 2023 Aug 16:ciad470. doi: 10.1093.
    >> Share

    May 2023
  4. CHU CS, Stolbrink M, Stolady D, Saito M, et al
    Severe falciparum and vivax malaria on the Thailand-Myanmar border: A review of 1503 cases.
    Clin Infect Dis. 2023 May 5:ciad262. doi: 10.1093.
    >> Share

    April 2023
  5. LYRA MR, Oliveira LFA, Schubach AO, Sampaio RN, et al
    A randomized, controlled, non-inferiority, multicenter trial of systemic versus intralesional treatment with meglumine antimoniate for cutaneous leishmaniasis in Brazil.
    Clin Infect Dis. 2023 Apr 26:ciad253. doi: 10.1093.
    >> Share

  6. ARONSON NE, Billick K
    Intralesional Antimonial Drug Treatment for Leishmania braziliensis Cutaneous Leishmaniasis: The Knowns and the Unknowns.
    Clin Infect Dis. 2023 Apr 26:ciad248. doi: 10.1093.
    >> Share

    February 2023
  7. BARBER BE, Abd-Rahman AN, Webster R, Potter AJ, et al
    Characterizing the blood stage antimalarial activity of tafenoquine in healthy volunteers experimentally infected with Plasmodium falciparum.
    Clin Infect Dis. 2023 Feb 16:ciad075. doi: 10.1093.
    >> Share

  8. WHITE NJ
    The antimalarial activity of tafenoquine in falciparum malaria.
    Clin Infect Dis. 2023 Feb 16:ciad079. doi: 10.1093.
    >> Share

  9. BLANKEN SL, Soumare HDM, Andolina C, Lanke K, et al
    How to Interpret Parasite Persistence and Transmission to Mosquitoes After Antimalarial Treatment in Kenya?
    Clin Infect Dis. 2023;76:555-557.
    >> Share

    December 2022
  10. FUKUDA N, Balikagala B, Ueno T, Anywar DA, et al
    The impact of sequestration on artemisinin-induced parasite clearance in Plasmodium falciparum malaria in Africa.
    Clin Infect Dis. 2022 Dec 15:ciac944. doi: 10.1093.
    >> Share

    September 2022
  11. MUSA AM, Mbui J, Mohammed R, Olobo J, et al
    Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial.
    Clin Infect Dis. 2022 Sep 27. pii: 6718130. doi: 10.1093.
    >> Share

    June 2022
  12. WEBSTER R, Mitchell H, Peters JM, Heunis J, et al
    Transmission blocking activity of low dose tafenoquine in healthy volunteers experimentally infected with Plasmodium falciparum.
    Clin Infect Dis. 2022 Jun 22. pii: 6613332. doi: 10.1093.
    >> Share

    April 2022
  13. NIANG M, Sandfort M, Mbodj AF, Diouf B, et al
    Correction to: Fine-scale Spatiotemporal Mapping of Asymptomatic and Clinical Plasmodium falciparum Infections: Epidemiological Evidence for Targeted Malaria Elimination Interventions.
    Clin Infect Dis. 2022 Apr 26. pii: 6574503. doi: 10.1093.
    >> Share

  14. IPPOLITO MM, Kabuya JB, Hauser M, Kamavu LK, et al
    Whole blood transfusion for severe malarial anemia in a high Plasmodium falciparum transmission setting.
    Clin Infect Dis. 2022 Apr 19. pii: 6570805. doi: 10.1093.
    >> Share

  15. CARVALHO AM, Viana SM, Andrade BB, Oliveira F, et al
    Immune response to LinB13, a Lutzomyia intermedia salivary protein correlates with disease severity in tegumentary leishmaniasis.
    Clin Infect Dis. 2022 Apr 6. pii: 6564311. doi: 10.1093.
    >> Share

    February 2022
  16. BURZA S, Mahajan R, Kazmi S, Alexander N, et al
    AmBisome monotherapy and combination AmBisome - miltefosine therapy for the treatment of visceral leishmaniasis in patients co-infected with HIV in India: a randomised open label, parallel arm, phase 3 trial.
    Clin Infect Dis. 2022 Feb 11. pii: 6527047. doi: 10.1093.
    >> Share

    December 2021
  17. MOHANTY S, Sahu PK, Pattnaik R, Majhi M, et al
    Evidence of Brain Alterations in Noncerebral Falciparum Malaria.
    Clin Infect Dis. 2021 Dec 15. pii: 6460593. doi: 10.1093.
    >> Share

    September 2021
  18. OUATTARA M, Bassa FK, Diakite NR, Hattendorf J, et al
    Effectiveness of Four Different Interventions against Schistosoma haematobium in a Seasonal Transmission Setting of Cote d'Ivoire: A Cluster Randomized Trial.
    Clin Infect Dis. 2021 Sep 14. pii: 6369964. doi: 10.1093.
    >> Share

    August 2021
  19. SCHMITT EK, Ndayisaba G, Yeka A, Asante KP, et al
    Efficacy of cipargamin (KAE609) in a randomized, Phase II dose-escalation study in adults in sub-Saharan Africa with uncomplicated Plasmodium falciparum malaria.
    Clin Infect Dis. 2021 Aug 19. pii: 6354946. doi: 10.1093.
    >> Share

  20. CLARK J, Arinaitwe M, Nankasi A, Faust CL, et al
    Reconciling egg- and antigen-based estimates of Schistosoma mansoni clearance and reinfection: a modelling study.
    Clin Infect Dis. 2021 Aug 6. pii: 6343396. doi: 10.1093.
    >> Share

    July 2021
  21. FAN H, Gai W, Zhang L, Ma Y, et al
    Parasite Circulating Cell-free DNA in the Blood of Alveolar Echinococcosis Patients as a Diagnostic and Treatment-Status Indicator.
    Clin Infect Dis. 2021;73:e246-e251.
    >> Share

    May 2021
  22. KAMRAN M, Ejazi SA, Choudhury ST, Bhattacharyya A, et al
    A novel antigen, otubain cysteine peptidase of Leishmania donovani improves serodiagnosis of visceral leishmaniasis and monitors treatment response.
    Clin Infect Dis. 2021 May 13. pii: 6275590. doi: 10.1093.
    >> Share

    April 2021
  23. AYABINA D, Kura K, Toor J, Graham M, et al
    Maintaining low prevalence of Schistosoma mansoni: modelling the effect of less frequent treatment.
    Clin Infect Dis. 2021 Apr 28. pii: 6256990. doi: 10.1093.
    >> Share

  24. COFFENG LE, Le Rutte EA, Munoz J, Adams E, et al
    Antibody and antigen prevalence as indicators of ongoing transmission or elimination of visceral leishmaniasis: a modelling study.
    Clin Infect Dis. 2021 Apr 27. pii: 6255961. doi: 10.1093.
    >> Share

  25. COFFENG LE, Levecke B, Hattendorf J, Walker M, et al
    Survey design to monitor drug efficacy for the control of soil-transmitted helminthiasis and schistosomiasis.
    Clin Infect Dis. 2021 Apr 27. pii: 6255959. doi: 10.1093.
    >> Share

  26. SUMNER KM, Freedman E, Mangeni JN, Obala AA, et al
    Exposure to diverse Plasmodium falciparum genotypes shapes the risk of symptomatic malaria in incident and persistent infections: A longitudinal molecular epidemiologic study in Kenya.
    Clin Infect Dis. 2021 Apr 27. pii: 6255633. doi: 10.1093.
    >> Share

    September 2019
  27. STEINHARDT LC, Richie TL, Yego R, Akach D, et al
    Safety, tolerability, and immunogenicity of PfSPZ Vaccine administered by direct venous inoculation to infants and young children: findings from an age de-escalation, dose-escalation double-blinded randomized, controlled study in western Kenya.
    Clin Infect Dis. 2019 Sep 26. pii: 5573993. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016